Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.
Xiao, Bo; Zhang, Zhan; Viennois, Emilie; Kang, Yuejun; Zhang, Mingzhen; Han, Moon Kwon; Chen, Jiucun; Merlin, Didier.
; 6(12): 2250-2266, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27924161
Antitumor activity of an anti-CD98 antibody.
CD98-Mediated Adhesive Signaling Enables the Establishment and Propagation of Acute Myelogenous Leukemia.
Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice.
CD147-CD98hc complex contributes to poor prognosis of non-small cell lung cancer patients through promoting cell proliferation via the PI3K/Akt signaling pathway.
Oral administration of ginger-derived nanolipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis.
Targeting intestinal inflammation with CD98 siRNA/PEI-loaded nanoparticles.
Efficacy of system l amino acid transporter 1 inhibition as a therapeutic target in esophageal squamous cell carcinoma.
CD98 marks a subpopulation of head and neck squamous cell carcinoma cells with stem cell properties.
Identification of anti-CD98 antibody mimotopes for inducing antibodies with antitumor activity by mimotope immunization.
Membrane protein 4F2/CD98 is a cell surface receptor involved in the internalization and trafficking of human ß-Defensin 3 in epithelial cells.